Proteomics analysis of enzalutamide-treated castration-sensitive and castration-resistant prostate cancer cell lines

被引：0
|
作者：
Liburd, Lincoln E., II
Paromov, Victor
Pratap, Siddharth
Stewart, LaMonica
机构：
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2024年 / 33卷 / 09期
关键词：
D O I：
10.1158/1538-7755.DISP24-C052
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C052
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Hoang, Anh
    Karlou, Maria
    Ashe, Robynne
    Tu, Shi Ming
    Aparicio, Ana
    Troncoso, Patricia
    Mohler, James
    Logothetis, Christopher J.
    EUROPEAN UROLOGY, 2015, 67 (01) : 53 - 60
  • [2] Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancer
    MacVicar, Gary R.
    Hussain, Maha H.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 252 - 260
  • [3] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [4] Enzalutamide in Castration-Resistant Prostate Cancer
    Anker, Markus S.
    Lehmann, Lorenz H.
    Anker, Stefan D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1380
  • [5] Early PSA progression in abiraterone/enzalutamide-treated patients with metastatic castration-resistant prostate cancer.
    Lopez-Campos, Fernando
    Gomez-Iturriaga, Alfonso
    Llacer Perez, Casilda
    Henriquez, Ivan
    Peleteiro, Paula
    Lozano, Rebeca
    Castano, Ana
    Romero-Laorden, Nuria
    Molina-Cerrillo, Javier
    Alvarez-Rodriguez, Sara
    Piquer, Teresa
    Navarro-Castellon, Joaquin
    Jose Conde-Moreno, Antonio
    Ramirez-Backhaus, Miguel
    Barrionuevo, Patricia
    Garcia, Raquel
    de los Llanos Perez-Haro, Maria
    Castro, Elena
    Olmos, David
    Lorente, David
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer
    De Laere, Bram
    Oeyen, Steffi
    Van Oyen, Peter
    Ghysel, Christophe
    Ampe, Jozef
    Ost, Piet
    Demey, Wim
    Hoekx, Lucien
    Schrijvers, Dirk
    Brouwers, Barbara
    Lybaert, Willem
    Everaert, Els
    Van Kerckhove, Piet
    De Maeseneer, Daan
    Strijbos, Michiel
    Bols, Alain
    Fransis, Karen
    Beije, Nick
    de Kruijff, Inge
    van Dam, Valerie
    Brouwer, Anja
    van Dam, Pieter-Jan
    Van den Eynden, Gert
    Rutten, Annemie
    Sleijfer, Stefan
    Vandebroek, Jean
    Van Laere, Steven
    Dirix, Luc
    PROSTATE, 2018, 78 (06): : 435 - 445
  • [7] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381
  • [8] Enzalutamide: A Review in Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Drugs, 2018, 78 : 1913 - 1924
  • [9] Enzalutamide for Patients with castration-resistant Prostate Cancer
    Kessing, Richard
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [10] ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
    Ha, Y-S
    Goodin, S.
    DiPaola, R. S.
    Kim, I. Y.
    DRUGS OF TODAY, 2013, 49 (01) : 7 - 13
12345